Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further Research

Maria Rosa Costanzo, Claudio Ronco, William T. Abraham, Piergiuseppe Agostoni, Jonathan Barasch, Gregg C. Fonarow, Stephen S. Gottlieb, Brian E. Jaski, Amir Kazory, Allison P. Levin, Howard R. Levin, Giancarlo Marenzi, Wilfried Mullens, Dan Negoianu, Margaret May Redfield, W. H.Wilson Tang, Jeffrey M. Testani, Adriaan A. Voors

Research output: Contribution to journalReview article

29 Citations (Scopus)

Abstract

More than 1 million heart failure hospitalizations occur annually, and congestion is the predominant cause. Rehospitalizations for recurrent congestion portend poor outcomes independently of age and renal function. Persistent congestion trumps serum creatinine increases in predicting adverse heart failure outcomes. No decongestive pharmacological therapy has reduced these harmful consequences. Simplified ultrafiltration devices permit fluid removal in lower-acuity hospital settings, but with conflicting results regarding safety and efficacy. Ultrafiltration performed at fixed rates after onset of therapy-induced increased serum creatinine was not superior to standard care and resulted in more complications. In contrast, compared with diuretic agents, some data suggest that adjustment of ultrafiltration rates to patients’ vital signs and renal function may be associated with more effective decongestion and fewer heart failure events. Essential aspects of ultrafiltration remain poorly defined. Further research is urgently needed, given the burden of congestion and data suggesting sustained benefits of early and adjustable ultrafiltration.

Original languageEnglish (US)
Pages (from-to)2428-2445
Number of pages18
JournalJournal of the American College of Cardiology
Volume69
Issue number19
DOIs
StatePublished - May 16 2017

Fingerprint

Ultrafiltration
Heart Failure
Research
Creatinine
Kidney
Vital Signs
Serum
Diuretics
Hospitalization
Research Design
Pharmacology
Safety
Equipment and Supplies
Therapeutics

Keywords

  • biomarkers
  • creatinine
  • diuretics
  • glomerular filtration rate
  • venous congestion

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure : Current Status and Prospects for Further Research. / Costanzo, Maria Rosa; Ronco, Claudio; Abraham, William T.; Agostoni, Piergiuseppe; Barasch, Jonathan; Fonarow, Gregg C.; Gottlieb, Stephen S.; Jaski, Brian E.; Kazory, Amir; Levin, Allison P.; Levin, Howard R.; Marenzi, Giancarlo; Mullens, Wilfried; Negoianu, Dan; Redfield, Margaret May; Tang, W. H.Wilson; Testani, Jeffrey M.; Voors, Adriaan A.

In: Journal of the American College of Cardiology, Vol. 69, No. 19, 16.05.2017, p. 2428-2445.

Research output: Contribution to journalReview article

Costanzo, MR, Ronco, C, Abraham, WT, Agostoni, P, Barasch, J, Fonarow, GC, Gottlieb, SS, Jaski, BE, Kazory, A, Levin, AP, Levin, HR, Marenzi, G, Mullens, W, Negoianu, D, Redfield, MM, Tang, WHW, Testani, JM & Voors, AA 2017, 'Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further Research', Journal of the American College of Cardiology, vol. 69, no. 19, pp. 2428-2445. https://doi.org/10.1016/j.jacc.2017.03.528
Costanzo, Maria Rosa ; Ronco, Claudio ; Abraham, William T. ; Agostoni, Piergiuseppe ; Barasch, Jonathan ; Fonarow, Gregg C. ; Gottlieb, Stephen S. ; Jaski, Brian E. ; Kazory, Amir ; Levin, Allison P. ; Levin, Howard R. ; Marenzi, Giancarlo ; Mullens, Wilfried ; Negoianu, Dan ; Redfield, Margaret May ; Tang, W. H.Wilson ; Testani, Jeffrey M. ; Voors, Adriaan A. / Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure : Current Status and Prospects for Further Research. In: Journal of the American College of Cardiology. 2017 ; Vol. 69, No. 19. pp. 2428-2445.
@article{5ac08baa460d4686b72fc88e795aa045,
title = "Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further Research",
abstract = "More than 1 million heart failure hospitalizations occur annually, and congestion is the predominant cause. Rehospitalizations for recurrent congestion portend poor outcomes independently of age and renal function. Persistent congestion trumps serum creatinine increases in predicting adverse heart failure outcomes. No decongestive pharmacological therapy has reduced these harmful consequences. Simplified ultrafiltration devices permit fluid removal in lower-acuity hospital settings, but with conflicting results regarding safety and efficacy. Ultrafiltration performed at fixed rates after onset of therapy-induced increased serum creatinine was not superior to standard care and resulted in more complications. In contrast, compared with diuretic agents, some data suggest that adjustment of ultrafiltration rates to patients’ vital signs and renal function may be associated with more effective decongestion and fewer heart failure events. Essential aspects of ultrafiltration remain poorly defined. Further research is urgently needed, given the burden of congestion and data suggesting sustained benefits of early and adjustable ultrafiltration.",
keywords = "biomarkers, creatinine, diuretics, glomerular filtration rate, venous congestion",
author = "Costanzo, {Maria Rosa} and Claudio Ronco and Abraham, {William T.} and Piergiuseppe Agostoni and Jonathan Barasch and Fonarow, {Gregg C.} and Gottlieb, {Stephen S.} and Jaski, {Brian E.} and Amir Kazory and Levin, {Allison P.} and Levin, {Howard R.} and Giancarlo Marenzi and Wilfried Mullens and Dan Negoianu and Redfield, {Margaret May} and Tang, {W. H.Wilson} and Testani, {Jeffrey M.} and Voors, {Adriaan A.}",
year = "2017",
month = "5",
day = "16",
doi = "10.1016/j.jacc.2017.03.528",
language = "English (US)",
volume = "69",
pages = "2428--2445",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "19",

}

TY - JOUR

T1 - Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure

T2 - Current Status and Prospects for Further Research

AU - Costanzo, Maria Rosa

AU - Ronco, Claudio

AU - Abraham, William T.

AU - Agostoni, Piergiuseppe

AU - Barasch, Jonathan

AU - Fonarow, Gregg C.

AU - Gottlieb, Stephen S.

AU - Jaski, Brian E.

AU - Kazory, Amir

AU - Levin, Allison P.

AU - Levin, Howard R.

AU - Marenzi, Giancarlo

AU - Mullens, Wilfried

AU - Negoianu, Dan

AU - Redfield, Margaret May

AU - Tang, W. H.Wilson

AU - Testani, Jeffrey M.

AU - Voors, Adriaan A.

PY - 2017/5/16

Y1 - 2017/5/16

N2 - More than 1 million heart failure hospitalizations occur annually, and congestion is the predominant cause. Rehospitalizations for recurrent congestion portend poor outcomes independently of age and renal function. Persistent congestion trumps serum creatinine increases in predicting adverse heart failure outcomes. No decongestive pharmacological therapy has reduced these harmful consequences. Simplified ultrafiltration devices permit fluid removal in lower-acuity hospital settings, but with conflicting results regarding safety and efficacy. Ultrafiltration performed at fixed rates after onset of therapy-induced increased serum creatinine was not superior to standard care and resulted in more complications. In contrast, compared with diuretic agents, some data suggest that adjustment of ultrafiltration rates to patients’ vital signs and renal function may be associated with more effective decongestion and fewer heart failure events. Essential aspects of ultrafiltration remain poorly defined. Further research is urgently needed, given the burden of congestion and data suggesting sustained benefits of early and adjustable ultrafiltration.

AB - More than 1 million heart failure hospitalizations occur annually, and congestion is the predominant cause. Rehospitalizations for recurrent congestion portend poor outcomes independently of age and renal function. Persistent congestion trumps serum creatinine increases in predicting adverse heart failure outcomes. No decongestive pharmacological therapy has reduced these harmful consequences. Simplified ultrafiltration devices permit fluid removal in lower-acuity hospital settings, but with conflicting results regarding safety and efficacy. Ultrafiltration performed at fixed rates after onset of therapy-induced increased serum creatinine was not superior to standard care and resulted in more complications. In contrast, compared with diuretic agents, some data suggest that adjustment of ultrafiltration rates to patients’ vital signs and renal function may be associated with more effective decongestion and fewer heart failure events. Essential aspects of ultrafiltration remain poorly defined. Further research is urgently needed, given the burden of congestion and data suggesting sustained benefits of early and adjustable ultrafiltration.

KW - biomarkers

KW - creatinine

KW - diuretics

KW - glomerular filtration rate

KW - venous congestion

UR - http://www.scopus.com/inward/record.url?scp=85019115004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019115004&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2017.03.528

DO - 10.1016/j.jacc.2017.03.528

M3 - Review article

C2 - 28494980

AN - SCOPUS:85019115004

VL - 69

SP - 2428

EP - 2445

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 19

ER -